Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
177.88
+0.46 (0.26%)
At close: Dec 26, 2025, 4:00 PM EST
177.98
+0.10 (0.06%)
After-hours: Dec 26, 2025, 7:45 PM EST
Insmed Stock Forecast
Stock Price Forecast
The 19 analysts that cover Insmed stock have a consensus rating of "Strong Buy" and an average price target of $185.84, which forecasts a 4.47% increase in the stock price over the next year. The lowest target is $115 and the highest is $256.
Price Target: $185.84 (+4.47%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 10 | 10 | 10 |
| Buy | 8 | 8 | 8 | 7 | 7 | 9 |
| Hold | 0 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 19 | 19 | 19 | 19 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $269 → $241 | Strong Buy | Maintains | $269 → $241 | +35.48% | Dec 18, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $258 → $225 | Strong Buy | Maintains | $258 → $225 | +26.49% | Dec 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $240 → $230 | Strong Buy | Maintains | $240 → $230 | +29.30% | Dec 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $230 → $221 | Strong Buy | Maintains | $230 → $221 | +24.24% | Dec 18, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $215 → $195 | Buy | Maintains | $215 → $195 | +9.62% | Dec 18, 2025 |
Financial Forecast
Revenue This Year
523.56M
from 363.71M
Increased by 43.95%
Revenue Next Year
1.21B
from 523.56M
Increased by 130.35%
EPS This Year
-6.33
from -5.57
EPS Next Year
-3.62
from -6.33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 567.5M | 1.6B | ||||
| Avg | 523.6M | 1.2B | ||||
| Low | 440.0M | 882.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 56.0% | 198.7% | ||||
| Avg | 44.0% | 130.3% | ||||
| Low | 21.0% | 68.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -6.14 | -2.17 | ||||
| Avg | -6.33 | -3.62 | ||||
| Low | -6.78 | -5.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.